首页 News 正文

Danish pharmaceutical company Novo Nordisk announced on Friday that it will invest 864 million Brazilian reals ($158.2 million) to renovate a factory in Brazil that produces a quarter of Novo Nordisk's global insulin production. Novo Nordisk stated in a statement that this funding will be used for a comprehensive overhaul of the Montesquiros factory located in the southeastern state of Minas Gerais, Brazil, and to implement sustainable development projects at the factory.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

阿豆学长长ov 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    27